VolitionRX Limited (VNRX) Earnings Call Analysis
AMEX · Healthcare · Diagnostics & Research
Earnings Reports
-
VolitionRx (VNRX) Q1 2026: Revenue Jumps 300% as Licensing Pipeline Expands to 12 Major Partners
May 15, 2026
-
VolitionRx (VNRX) Q4 2025: 133% Q4 Revenue Surge Signals Commercialization Pivot
April 01, 2026
-
VolitionRx (VNRX) Q3 2025: Operating Expenses Down 10% as Licensing Pipeline Accelerates
November 14, 2025
-
VolitionRx (VNRX) Q2 2025: Operating Expenses Down 9% as Cost Controls Tighten Cash Burn
August 15, 2025